E5 monoclonal antibody: Phase III trial

XOMA Corp. (XOMA), Berkeley, Calif. Product: E5 monoclonal antibody Indication: Gram-negative sepsis Status: The first of two interim analyses in an ongoing, 1,700-patient Phase III trial was complete...